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Endothelial nitric oxide synthase (NOS3) is involved in key steps of immune response. Genetic factors 
predispose individuals to periodontal disease. This study's aim was to explore the association between 
NOS3 gene polymorphisms and clinical parameters in patients with periodontal disease. Genomic DNA 
was obtained from the peripheral blood of 23 subjects with aggressive periodontitis (AgP), 26 with 
chronic periodontitis (CP), 31 with gingivitis (G) and 50 healthy controls. Probing depth (PD), clinical 
attachment loss (CAL), plaque index (PI) and gingival index (GI) were recorded as clinical parameters. 
We genotyped NOS3 polymorphisms using the PCR and/or PCR-RFLP method. Genotype frequencies 
differed significantly among periodontal diseases and controls for these polymorphisms. A significant 
association was detected between NOS3 +894 polymorphism and PD and CAL in the CP and AgP 
patient groups; whereas NOS VNTR analysis detected no associations with clinical parameters in the 
CP and AgP groups. However, a significant association was detected between the AA genotype and 
both PI and GI in patients with gingivitis; and a significant association was shown between the BB 
genotype and PI. The present study shows that two common polymorphisms of the NOS3 gene cluster 
are significantly associated with the occurrence of periodontal diseases. 
 





Periodontal disease is one of most common chronic 
inflammatory disorders that has a primarily bacterial 
etiology and affects teeth and supporting tissue, including 
bone (Brown and Löe, 1993). Previous clinical studies 
have proven the genetic origin of periodontitis 
(Michalowicz et al., 2000; Loss et al., 2005).  
Nitric oxide (NO) is an important mediator of immunity 
and inflammation; it is the most powerful endogenous 
vasodilator known and it also regulates cells' adhesion to 
the endothelium and inhibits platelets' aggregation and 
vascular smooth muscle cells' proliferation (Andrew and 
Mayer, 1999; Freedman et al., 1997). It is implicated in 
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as a modulator of immunity and a key mediator in host-
mediated destruction (Moilanen and Vapaatalo, 1995). 
Nitric oxide is a free radical synthesized from L-arginine 
by a member of the family of nitric oxide syntheses 
(NOS) enzymes. Endothelial NOS (NOS3) is one of the 
three isoforms of NOS (Hattori et al., 1994). The NOS3 
gene is mapped to the human chromosome 7q35-36 and 
encodes for NOS3, an enzyme that catalyzes the 
production of the free radical NO by converting L-arginine 
to L-citrulline within endothelial cells and platelets (Walch 
et al., 2008). The exon 7 Glu298Asp missense variant 
and the intron 4 27-base pair (bp) variable number of 
tandem repeat (VNTR) polymorphism of NOS3 are postu-
lated to be associated with altered NOS3 function, 
leading to impaired NO synthesis (Walch et al., 2008). 
These polymorphisms are reportedly associated with 
complications of preeclampsia (Serrano et al., 2004), 
Behcet’s disease (Karasneh et al., 2005), diabetes (Monti  




Table 1. NOS3 +894 and intron 4 VNTR primer sequences and PCR conditions. 
 
NOS3 regions Primer sequence Annealing 
+894 CATGAGGCTCAGCCCCAGAAC AGTCAATCCCTTTGGTGCTCAC 58°C and 30 cycles 




et al., 2003) and several cardiovascular diseases (Casas 
et al., 2004). Considering the proposed mechanisms of 
linkages between periodontal disease and systemic 
diseases, NOS3 polymorphism might provide evidence of 
the association between periodontal and systemic disea-
ses (Berdeli et al., 2006).  
The present study's purpose was to evaluate: 1) the 
genotype distribution of NOS3 polymorphisms and 2) its 
relation to different forms of periodontal disease severity 
in Turkish patients with AgP, CP and gingivitis. 
 
 




This study was performed at the Department of Periodontology, 
Gaziantep University Faculty of Dentistry. The Gaziantep University 
School of Medicine's Ethical Committee approved the study. The 
study group included 23 subjects with AgP, 26 subjects with CP, 31 
subjects with gingivitis and 50 healthy controls. All of the healthy 
controls were systemically healthy and non-smokers. The patients 
and controls were informed of the study's purpose and method and 
they all agreed to participate. The exclusion criteria were preg-
nancy, lactation period and intake of antibiotics or anti-inflammatory 
drugs in the previous 6 months, systemic diseases with influence 
on periodontitis. A detailed medical, oral and family medical history 
was taken, followed by a complete periodontal examination. For 
periodontitis patients, measurements of probing depth (PD) and 
clinical attachment loss (CAL) were made at six sites (mesiobuccal, 
buccal, distobuccal, mesiolingual/palatal, palatal/lingual and dis-
tolingual/palatal) for each tooth using a manual periodontal probe 
(Carl Martin, Solingen, Germany). Gingival index (GI) (Löe and 
Silness, 1963) and plaque index (PI) (Silness and Löe, 1964) were 
recorded at four sites (mesiobuccal, buccal, distobuccal and palatal/ 
lingual). The patients were diagnosed according to the criteria of 
the IWC 1999 International Workshop for Classification of Perio-
dontal Diseases and Conditions (Armitage, 1999) and were 
assigned as having aggressive periodontitis (AgP), chronic perio-
dontitis (CP), or gingivitis (G). The patients and controls were from 





Genomic DNA was extracted from mononuclear cells obtained from 
EDTA-treated peripheral venous blood using the salting-out method 
(Miller et al., 1988).  
 
 
NOS3 894 G > T genotyping 
 
A polymerase chain reaction (PCR) was used to amplify a 206 bp 
fragment (Table 1). The resulting fragment was digested with MboI 
restriction endonuclease (Invitrogen, Carlsbad, CA, USA) overnight 
at 37°C. Digestion was resolved on 3% agarose gel and visualized 
using ultraviolet light. The 206 bp PCR products had a consistent 
restriction site resulting in a 119 and 87 bp fragment. Twenty 
percent of the samples were duplicated as an internal quality 
control to avoid sampling or reading errors (Hingorani et al., 1999). 
 
 
NOS3 intron 4 VNTR genotyping 
 
Primers were designed to amplify a 393 and/or 420 bp segment of 
the NOS3 intron 4 VNTR region containing the microsatellite repeat 
sequence (Table 1) (Walch et al., 2008). The products were then 
separated on 4% NuSieve GTG agarose. The experimental process 





Data were analyzed using the computer software SPSS for Win-
dows (version 13.0; SPSS, Inc., Chicago, IL, USA). The statistical 
significance of the differences between the patient and control 
groups was estimated by logistic regression analysis. Adjusted 
odds ratios (ORs) were calculated with a logistic regression model 
that controlled for gender and age and were reported to be at 95% 
confidence intervals (CI). Differences in NOS3 allele frequencies 
between the control group and patients were compared with a chi-
square test and when needed, Fisher's exact test was used. The 
Hardy-Weinberg equation was used to calculate estimated 
genotype frequency and experienced genotype frequency. For 
statistical comparisons between groups, a Mann-Whitney U-test 






The study group included 23 subjects with AgP, 26 sub-
jects with CP, 31 subjects with G and 50 healthy 
volunteers. The patients and controls were from the same 
geographical areas. Demographic and clinical data of 
patients with AgP, CP, G and control groups are given in 
Table 2.  
Table 3 shows the frequencies of the NOS3 gene 
polymorphisms in patients in the AgP, CP, G and C 
groups. Tables 4, 5 and 6 show comparisons between 
polymorphisms of the NOS3 gene and clinical para-





Periodontal diseases affect millions of people around the 
world. Current knowledge of these diseases' pathogenesis  




Table 2 Clinical feature with periodontal diseases and controls. 
 
CP AgP G Healthy control Clinical 
feature  n a n b n c n d 
Age*  47 (36-68) 27 (18 - 38) 35 (14 - 58) 41 (20 - 65) 
Gender& Female/ Male 16/10 15/8 14/17 28/22 
PD mm 3.9 (±  0.54) 5.3 (± 0.73) 3.1 (± 0.23) 1.85 (± 0.27) 
CAL mm 4.5 (± 0.93) 5.6 (± 0.86) 2.8 (± 0.75) 1.90 (± 0.20) 
PI  2.2 (± 0.20) 1.9 (± 0.26) 2.1 (± 0.23) 0.27 (± 0.25) 
GI  2.0 (± 0.16) 2.0 (± 0.25) 2.0 (± 0.23) 0.49 (± 0.36) 
 
n a = 26, n b = 23, n c = 31, n d = 50, ± sdt. deviation, *median, &years.  
CP; chronic periodontitis, AgP; aggressive periodontitis, G; gingivitis, PD; probing depth, CAL; clinical attachment loss, 




Table 3. Comparison of frequencies of NOS (+894) and NOS VNTR gene polymorphisms between patients with periodontal 
diseases and healthy controls. 
 
CP AgP G Healthy control HWE OR 95% CI p  Genotype 














0.630  -  5.109 ad* 
0.225 - 2.902 bd* 




 AB 4 (15.4) 6 (26.1) 
11 






0.167 - 2.185 ad* 
0.168 - 2.500 bd* 








1.620 - 136.947 ad* 
0.102 - 35.502 bd* 

















0.272 - 2.365 ad* 
0.449 - 5.135 bd* 




 GT 3 (11.5) 9 (39.1) 
8 






0.073 - 1.122 ad* 
0.283 - 3.294 bd* 




 TT 4 (15.4) 3 (13.1) 
5 




2.310 - 4.636 ad& 
0.742 - 1.019 bd& 





n a = 26, n b  = 23, n c = 31, n d = 50, *:OR (95%CI) was adjusted by age and sex, &Fisher's Exact Test. HWE: Hardy-Weinberg 
Equilibrium. &, median test; *, OR (95% CI) was adjusted by age and sex; CP; chronic periodontitis, AgP; aggressive periodontitis, G; 
gingivitis, ad, comparison of genotypes frequencies between CP and healthy control groups; bd, comparison of genotypes frequencies 




suggests that they are multifactorial diseases resulting 
from the interaction between hosts and microbial factors 
(Reichert et al., 2008). Recent studies have improved our 
knowledge of an association between certain cytokine 
gene polymorphisms and periodontal disease (D’Aiuto et 
al., 2007; Feng et al., 2006). Individual factors that have a 
genetically determined hyper inflammatory response 
might increase the risk of severe periodontal disease 
(Kornman and di Giovine, 1998). NOS3 gene polymor-
phisms have been associated with preeclampsia 
(Serrano et al., 2004). Behcet’s disease (Karasneh et al., 
2005), cardiovascular diseases (Casas et al., 2004), 
cancer (Lee et al., 2009) and diabetes (Monti et al., 
2003), possibly, are linked with periodontal disease. 
Available data, however, provide evidence that the deve-
lopment of periodontal diseases is complex, is regulated 
by multiple genetic pathways and is modified by several 
exogenous factors. Berdeli et al. evaluated the genotype  




Table 4. Association between polymorphisms of the NOS gene and clinical parameters in chronic periodontitis. 
 
NOS VNTR n PD* p& CAL* p& PI* p& GI* p& 
AAa 16 3.81 (±  0.53) 0.294 ac 4.38 (± 0.69) 0.494 ac 2.11 (± 0.18) 0.590 ac 1.95 (± 0.17) 0.115 ac 
ABb 4 4.07 (± 0.76) 0.617 ab 4.77 (± 1.55) 0.963 ab 2.1 (± 0.21) 0.892 ab 1.97 (± 0.17) 0.892 ab 
BBc 6 4.03 (± 0.44) 0.762 bc 4.68 (± 1.14) 0.352 bc 2.15 (± 0.25) 0.762 bc 2.08 (± 0.09) 0.257 bc 
NOS (+894) 
GGd 19 3.76 (± 0.39) 0.001de 4.27 (± 0.53) 0.001de 2.11 (± 0.19) 0.523de 1.96 (± 0.17) 0.787de 
GTe 3 5.03 (± 0.15) 0.725df 6.63 (± 0.72) 0.409df 2.0 (± 0.3) 0.366df 2.0 (± 0.1) 0.162df 
TTf 4 3.72 (± 0.82) 0.057ef 4.07 (± 0.22) 0.057ef 2.22 (± 0.15) 0.229ef 2.1 (± 0.11) 0.400ef 
 
n = 26, * Mean mm, p&: Mann-Whitney U test, ± sdt. deviation, * PD; probing depth, CAL; clinical attachment loss, PI; plaque index, GI; gingival 
index, ab: Comparison of AA genotype and AB genotype, ac: Comparison of AA genotype and BB genotype, bc: Comparison of AB genotype and 
BB genotype, de: Comparison of GG genotype and GT genotype, df: Comparison of GG genotype and TT genotype, ef: Comparison of GT 




Table 5. Association between polymorphisms of the NOS gene and clinical parameters in aggressive periodontitis. 
 
NOS VNTR n PD* p& CAL* p& PI* p& GI* p& 
AAa 15 5.31 (±  0.86) 0.941 ac 5.77 (± 0.99) 0.368 ac 1.96 (± 0.27) 0.441 ac 2.04 (± 0.22) 0.088 ac 
ABb 6 5.18 (± 0.42) 1.000 ab 5.20 (± 0.26) 0.178 ab 1.85 (± 0.29) 0.470 ab 1.88 (± 0.32) 0.569 ab 
BBc 2 5.40 (± 0.71) 0.857 bc 5.05 (± 0.35) 0.643 bc 1.80 (± 0.14) 0.857 bc 1.85 (± 0.07) 1.000 bc 
NOS (+894) 
GGd 10 4.91 (± 0.55) 0.105de 5.08 (± 0.43) 0.052de 1.85 (± 0.28) 0.481de 1.87 (± 0.29) 0.190de 
GTe 10 5.27 (± 0.48) 0.007df 5.58 (± 0.62) 0.007df 1.9 (± 0.21) 0.371df 2.02 (± 0.13) 0.112df 
TTf 3 6.60 (± 0.53) 0.014ef 7.10 (± 0.90) 0.014ef 2.0 (± 0.40) 0.811ef 2.23 (± 0.21) 0.112ef 
 
n = 23, * Mean mm, p&: Mann-Whitney U test, ± sdt. deviation, * PD; probing depth, CAL; clinical attachment loss, PI; plaque index, GI; gingival 
index, ab: Comparison of AA genotype and AB genotype, ac: Comparison of AA genotype and BB genotype, bc: Comparison of AB genotype and 
BB genotype, de: Comparison of GG genotype and GT genotype, df: Comparison of GG genotype and TT genotype, ef: Comparison of GT 




and allele distribution of the Glu298Asp polymorphism of 
the NOS3 gene and its relation to different forms of 
periodontal diseases' severity in Turkish patients with 
AgP and CP (Berdeli et al., 2006). Their study shows that 
NOS3 Glu298Asp polymorphism is associated with 
bleeding after probing in AgP patients and that the NOS3 
gene's 298Asp allele might be related to CP (Berdeli et 
al., 2006). In the present study, we investigated to esta-
blish for the first time, to the best of our knowledge, an 
association between two well-established polymor-
phisms of the NOS3 gene cluster and clinical parameters 
in different forms of periodontal disease.  
When the results of the G and control groups with 
respect to the NOS3 +894 polymorphism; were compared 
in terms of HWE, a deviation from HWE appeared in the 
G patient group; whereas no deviations were observed in 
the control groups (Table 3). An increase in the TT 
genotype with a decrease in the GG genotype in the 
patient group revealed that it might be related to suscep-
tibility to G. In conclusion, patients with the T allele had 
an 8.7 times greater risk of gingivitis than patients without 
this allele (Table 3). No deviations from HWE in NOS3 
VNTR polymorphism were observed in either the patient 
or the control group and no associations were detected in  
terms of allele or genotype frequency (Table 3). 
When the NOS3+894 polymorphism in the CP and 
control groups were compared in terms of HWE, a 
deviation from HWE was present in the CP group, but no 
deviations from HWE were present in the control group 
(Table 3). Although no significant associations were 
detected between the CP and control groups in terms of 
allele frequency, the results show that the TT genotype 
significantly increased in the CP group and that it might 
be associated with susceptibility to CP (Table 3). When 
the NOS3 VNTR polymorphism in the CP and control 
groups was compared in terms of HWE, a deviation from 
HWE was noted in the CP group, but no deviations were 
present in the control group (Table 3). A significant 
association was present in terms of allele and genotype 
frequencies. The B allele was associated with suscep-
tibility to periodontal disease and patients with that allele 
had about 8 times greater risk for CP than patients 
without it (Table 3).  
No significant associations were detected in terms of 
HWE in the analysis of the NOS3+894 polymorphism in 
either the AgP or the control group; whereas a significant 
association was present in terms of allele and genotype 
frequencies (Table 3). The  TT  genotype  or  the  T allele  




Table 6. Association between polymorphisms of the NOS gene and clinical parameters in gingivitis. 
 
NOS VNTR n PD* p& CAL* p& PI* p& GI* p& 
AAa 17 3.12 (±  0.23) 0.689 ac 2.80 (± 0.88) 0.305 ac 2.04 (± 0.19) 0.002 ac 1.95 (± 0.21) 0.028 ac 
ABb 11 3.03 (± 0.22) 0.487 ab 2.83 (± 0.32) 0.122 ab 2.14 (± 0.23) 0.191 ab 2.03 (± 0.22) 0.611 ab 
BBc 3 3.07 (± 0.25) 0.885 bc 2.33 (± 1.15) 1.000 bc 2.43 (± 0.57) 0.022 bc 2.30 (± 0.20) 0.088 bc 
NOS (+894)          
GGd 18 3.08 (± 0.23) 0.935de 2.77 (± 0.76) 0.683de 2.14 (± 0.24) 0.724de 2.03 (± 0.24) 0.849de 
GTe 8 3.10 (± 0.24) 0.638df 2.79 (± 0.75) 0.801df 2.10 (± 0.25) 0.325df 2.02 (± 0.26) 0.403df 
TTf 5 3.04 (± 0.21) 0.724ef 2.70 (± 0.87) 0.943ef 2.04 (± 0.19) 0.622ef 1.92 (± 0.16) 0.354ef 
 
n = 31, * Mean mm, p&: Mann-Whitney U test, ± sdt. deviation, *PD; probing depth, CAL; clinical attachment loss, PI; plaque index, GI; gingival 
index, ab: Comparison of AA genotype and AB genotype, ac: Comparison of AA genotype and BB genotype, bc: Comparison of AB genotype and 
BB genotype, de: Comparison of GG genotype and GT genotype, df: Comparison of GG genotype and TT genotype, ef: Comparison of GT 




played a role in susceptibility to AgP and patients with the 
T allele had a 13.5 times greater risk for AgP than 
patients without it (Table 3). No deviations from HWE 
were observed in the NOS3 VNTR polymorphism in 
either the patient or control group, or no significant asso-
ciations were detected in terms of allele or genotype 
frequency (Table 3). 
The analysis of NOS3-894 found a significant asso-
ciation between PD, CAL and the GG and TT genotype in 
the CP group; and an association was demonstrated bet-
ween the GT and TT genotypes and PD and CAL in the 
AgP group (Tables 4 and 5). No associations between 
genotypes and these clinical parameters were detected in 
the gingivitis group (Table 6). The analysis of NOS VNTR 
detected no associations with clinical parameters in the 
CP or AgP groups (Tables 4 and 5). However, a signi-
ficant association was detected between the AA geno-
type and both PI and GI in the gingivitis group; whereas 
the findings show a significant association between the 
BB genotype and PI (Table 6). 
The alterations in the NOS3 protein's functional aspects 
might lead to exaggerated inflammation and periodontal 
tissue destruction because NOS3-mediated NO pro-
duction possibly protects tissues and possesses anti-
inflammatory features, particularly by conferring anti-ad-
hesive properties to the endothelium (Berdeli et al., 
2006). Therefore, the increased inflammation indicated 
by the significantly elevated percentage of GI and PI in 
VNTR subjects in the gingivitis group might be a result of 
insufficient vasoprotective NO production. Nevertheless, 
an association was detected between PD and CAL in the 
CP and AgP groups in NOS3+894, but no associations 
were detected in the gingivitis group.  
Within this study's limitations, NOS3 gene polymor-
phisms demonstrated a significant association with AgP, 
CP and gingivitis. The different associations of AgP, CP 
and gingivitis with these gene polymorphisms might help 
to explain these different periodontal diseases' differing 
aetiopathogeneses. However, these data can explain 
only a small portion of the genetic susceptibility to perio-
dontal disease. Furthermore, NOS3's possible role in 
different forms of periodontal diseases, including any 
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